Asthma heterogeneity and therapeutic options from the clinic to the bench

被引:13
作者
Bonfield, Tracey L. [1 ,2 ,3 ]
Ross, Kristie R. [1 ,2 ,3 ]
机构
[1] Case Western Reserve Univ, Dept Pulm, Div Pediat, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Dept Allergy, Div Pediat, Cleveland, OH 44106 USA
[3] Univ Hosp Cleveland, Cleveland, OH 44106 USA
关键词
asthma genetics; asthma therapeutics; cellular mechanisms; GENOME-WIDE ASSOCIATION; REGULATORY T-CELLS; DISEASE; PHENOTYPES; MICE; INFLAMMATION; CYTOKINES; MODELS; SAFETY; CD8(+);
D O I
10.1097/ACI.0b013e32834edb5b
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of review Asthma is a chronic pulmonary inflammatory disease affecting all races, children and adults. The causative or intrinsic development of asthma is diverse, ranging from episodic exposure to environmental insults to physical induction in exercise. Recent findings Asthma uniquely manifests in affected individuals as episodes of airway hyper-reactivity, chronic airway obstruction, and inflammation. The diversity in asthmatic phenotypes and the mechanisms that lead to initiation and perpetuation of the lung disease continue to make asthma a challenge to treat, classify, and manage therapeutically. Summary This review will focus on the newest of mechanistic insights into asthma development, therapeutic innovations, and clinical applications.
引用
收藏
页码:60 / 67
页数:8
相关论文
共 55 条
  • [1] Con: Genome-Wide Association Studies Have Not Been Useful in Understanding Asthma
    Adcock, Ian M.
    Barnes, Peter J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (06) : 633 - 636
  • [2] CD4+ invariant T-cell-receptor plus natural killer T cells in bronchial asthma.
    Akbari, O
    Faul, JL
    Hoyte, EG
    Berry, GJ
    Wahlström, J
    Kronenberg, M
    DeKruyff, RH
    Umetsu, DT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (11) : 1117 - 1129
  • [3] Insights into asthmatic airway remodelling through murine models
    Al Heialy, Saba
    McGovern, Toby K.
    Martin, James G.
    [J]. RESPIROLOGY, 2011, 16 (04) : 589 - 597
  • [4] [Anonymous], 1999, Control Clin Trials, V20, P91
  • [5] Biologic immune modifiers: Trials and tribulations - are we there yet?
    Ballow, Mark
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (06) : 1209 - 1215
  • [6] Cytokine modulators for allergic diseases
    Barnes, Peter J.
    [J]. CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 1 (06) : 555 - 560
  • [7] New advances and potential therapies for the treatment of asthma
    Belvisi, MG
    Hele, DJ
    Birrell, MA
    [J]. BIODRUGS, 2004, 18 (04) : 211 - 223
  • [8] Human asthma phenotypes: from the clinic, to cytokines, and back again
    Bhakta, Nirav R.
    Woodruff, Prescott G.
    [J]. IMMUNOLOGICAL REVIEWS, 2011, 242 : 220 - 232
  • [9] Natural versus adaptive regulatory T cells
    Bluestone, JA
    Abbas, AK
    [J]. NATURE REVIEWS IMMUNOLOGY, 2003, 3 (03) : 253 - 257
  • [10] Treatment of allergic asthma: Modulation of Th2 cells and their responses
    Bosnjak, Berislav
    Stelzmueller, Barbara
    Erb, Klaus J.
    Epstein, Michelle M.
    [J]. RESPIRATORY RESEARCH, 2011, 12